Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

AnaSpec Offers Beta-Amyloid (1-40) and (1-42) Peptides

Published: Tuesday, December 04, 2012
Last Updated: Tuesday, December 04, 2012
Bookmark and Share
HFIP treated peptides for the advancement of Alzheimer’s disease research.

AnaSpec, EGT Group has provided a whole suite of reagents for the advancement of Alzheimer’s disease (AD) research.

From peptides to assay kits to antibodies to dyes, AnaSpec is the trusted source of integrated proteomics solutions for AD research.

Amongst the more than 300 β-amyloid peptides, we offer β-amyloid (1-40) and (1-42) that are HFIP treated.

β-amyloids are amphiphilic peptides with a hydrophilic N-terminal domain (residues 1 to 28) and a hydrophobic C-terminal (residues 29 to 40-42), the latter corresponding to a part of the transmembrane domain of APP.

β-Amyloid assembly into fibrils is initiated by a conformational transition from random coil to β-sheet (hence the name β-amyloid) and a nucleation-dependent aggregation process.

Aβ peptides that are 39 to 42 amino acid residues in length with a molecular mass of approximately 4 kDa are the core components of neuritic plaques seen in Alzheimer’s disease (AD) brains.

Studies have found that dissolving in HFIP favors alpha helical structure and tends to be monomeric.

HFIP treatment of lyophilized Aβ-peptide results in a dense, homogeneous preparation of unaggregated peptide and samples can be stored as peptide films.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AnaSpec Signs Distribution Agreement with Gene X Press
Both company’s announces non-exclusive distributor agreement that will allow Gene X Press to distribute AnaSpec’s catalog and custom products throughout Chile.
Friday, February 18, 2011
AnaSpec Introduces BAFF Protein
Naïve B-cells when treated with 20-1000 ng/ml BAFF protein shows increased IgG secretion.
Wednesday, October 06, 2010
AnaSpec Signs Distribution Agreement with Bioeasy Diagnostica
Non-exclusive distributor agreement allows Bioeasy to distribute AnaSpec’s catalog and custom products throughout Brazil.
Friday, June 18, 2010
AnaSpec Products Used in Over 400 Patents
As compiled by Google Patent Search, the number of patents citing AnaSpec’s products has passed 400.
Monday, January 25, 2010
AnaSpec Introduces HiLyte Fluor™ 750
According to company, the new HiLyte Fluor™ 750 dye is the longest-wavelength HiLyte Fluor™ dye currently available.
Monday, January 04, 2010
AnaSpec Signs Distribution Agreement with Bioeksma UAB
The agreement allows Bioeksma UAB to distribute AnaSpec’s catalog and custom products throughout Lithuania and Latvia.
Thursday, June 04, 2009
AnaSpec Launches new Headquarters in Fremont, California
Company announces the launch of its 44,010 square foot facility to offer all top of the line lab/R&D equipment and services.
Wednesday, April 29, 2009
AnaSpec Signs Distribution Agreement with Yope Biotechnology
The non-exclusive distributor agreement allows Yope Biotechnology to distribute AnaSpec’s catalog and custom products throughout China.
Wednesday, December 03, 2008
AnaSpec Establishes new Dedicated GMP Manufacturing Facility
The expansion provides an additional 5000 sq. ft. of GMP space including two class 10,000 clean rooms.
Monday, November 17, 2008
AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
The licensing agreement allows AnaSpec to make, use, and sell deacetylase activity assay kits and the related products.
Monday, September 15, 2008
AnaSpec Introduces Longest Wavelength Assay Kit for TACE Detection
AnaSpec has introduced the SensoLyte™ 520 TACE Assay Kit, offering fluorescence detection at the wavelengths.
Thursday, August 23, 2007
Dr. Rich Meyer Joins AnaSpec to Lead Detection Reagents Division
Meyer is responsible for strengthening the product development strategy of AnaSpec’s detection reagents division.
Friday, August 25, 2006
Scientific News
How it Works: Advanced Data Analysis Using Visualization
Visualisation of data can be used to help molecular biologists tackle the vast datasets their experiments create.
Startup Seeks More Precise Prostate Cancer Screening
Gregor Diagnostics aims to bring a non-invasive prostate cancer screening test to the market.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Rare Immunodeficiency Yields Unexpected Insights
Scientists uncover previously unknown gene mutation revealing the role of a key molecule involved in immune cell development.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
IU Research Reveals Link between Molecular Mechanisms in Prostate Cancer and Ewing's sarcoma
Researchers at IU have suggested that the molecular mechanism that triggers the rare disease Ewing's sarcoma could act as a potential new direction for the treatment of more than half of patients with prostate cancer.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
RNA-Binding Proteins Role in ALS Revealed
Researchers describe how damage to RNA-binding protein contributes to ALS, isolating a possible therapeutic target.
Advances in Alzheimer’s Research
Researchers show how a diseased vertebrate brain can naturally react to Alzheimer’s pathology by forming more neurons.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos